| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Lyell Immunopharma, Inc. (LYEL) have been net sellers, shedding 14,188 shares worth roughly $215K on balance. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
The insider who sold still holds shares after the sale. LYEL sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.77M | - | - | |
| 10% | 1.43M | $36.53M | - | |
| 10% | 1.43M | $36.53M | - | |
| CEO | 63.9K | $993.0K | - | |
| Other | 20.4K | $259.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | Innovative Cellular Therapeutics Holdings Ltd | 10% Owner | Sell10b5-1 | 10 | $13.73 | $137.30 | - | -42.5% | - | |
| Jun 10, 2026 | Shook David53 | Chief Medical Officer | Sell | 1,977 | $12.64 | $24,989.28 | -8.6% | +2.3% | - | |
| May 11, 2026 | Lee Gary K. | Chief Scientific Officer | Sell | 130 | $18.92 | $2,459.60 | -0.7% | -25.4% | - | |
| May 11, 2026 | Seely Lynn74 | President and CEO | Sell | 388 | $18.91 | $7,337.08 | -0.5% | -25.4% | - | |
| May 11, 2026 | Hill Stephen J. | Chief Operating Officer | Sell | 89 | $18.92 | $1,683.88 | -0.5% | -25.4% | - | |
| May 11, 2026 | Bulis Veronica Sanchez54 | VP, Corporate Controller | Sell | 217 | $18.91 | $4,103.47 | -1.4% | -25.4% | - | |
| Mar 6, 2026 | Arch Venture Partners Ix, LLC | 10% Owner | Buy | 488,090 | $25.61 | $12,499,984.90 | +52.0% | -41.9% | - | |
| Mar 6, 2026 | Arch Venture Fund Xiii, L.P. | 10% Owner | Buy | 488,090 | $25.61 | $12,499,984.90 | +52.0% | -41.9% | - | |
| Feb 11, 2026 | Hill Stephen J. | Chief Operating Officer | Sell | 1,236 | $23.39 | $28,910.04 | -6.5% | -20.9% | - | |
| Feb 11, 2026 | Lee Gary K. | Chief Scientific Officer | Sell | 1,671 | $23.39 | $39,084.69 | -9.0% | -20.9% | - |